Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02756338 · ClinicalTrials.gov registry record
BioMonitor 2 In-Office Setting Insertion Safety and Feasibility Evaluation With Device Functionality Assessment
A clinical trial, sponsored by Biotronik.
- Completed
- Registry status
- 77
- Enrollment target
NCT02756338 is a clinical trial that has completed, run by Biotronik. The registered enrollment target is 77 participants.
The verdict
NCT02756338 has completed, sponsored by Biotronik.
- COMPLETED
- Registry status
- 77 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and feasibility of performing the BioMonitor 2 insertion procedure in an office setting.
Interventions
- DEVICE BioMonitor 2 Insertable Cardiac Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2016-06 |
| Est. Completion | 2017-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02756338
The ClinicalTrials.gov registry entry for NCT02756338 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biotronik, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BioMonitor 2 Insertable Cardiac Monitor is the first listed.
NCT02756338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02756338 about?
NCT02756338 is a clinical study titled "BioMonitor 2 In-Office Setting Insertion Safety and Feasibility Evaluation With Device Functionality Assessment". The purpose of this study is to evaluate the safety and feasibility of performing the BioMonitor 2 insertion procedure in an office setting.
What is the current status of trial NCT02756338?
This trial is currently completed. The enrollment target is 77 participants. The study started on 2016-06. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02756338?
The interventions under investigation include: BioMonitor 2 Insertable Cardiac Monitor (DEVICE).
Who is sponsoring clinical trial NCT02756338?
This trial is sponsored by Biotronik, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.